BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 7:36:00 PM | Browse: 906 | Download: 803
 |
Received |
|
2014-02-28 09:36 |
 |
Peer-Review Started |
|
2014-02-28 22:35 |
 |
To Make the First Decision |
|
2014-04-04 16:03 |
 |
Return for Revision |
|
2014-04-10 23:05 |
 |
Revised |
|
2014-05-01 03:10 |
 |
Second Decision |
|
2014-07-18 13:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-07-18 14:00 |
 |
Articles in Press |
|
2014-07-18 14:00 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-05 18:39 |
 |
Publish the Manuscript Online |
|
2014-08-17 13:16 |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Evidence-Based Medicine |
Article Title |
HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients
|
Manuscript Source |
Invited Manuscript |
All Author List |
Mariana Fernández, Matías Fabregat, Gerardo Javiel and Adriana Mimbacas |
Funding Agency and Grant Number |
|
Corresponding Author |
Adriana Mimbacas, PhD, Biodiversity and Genetic Department, Instituto de Investigaciones Biológicas Clemente Estable, Avenida Italia 3318, Montevideo, CP 11600, Uruguay. amimbacas@iibce.edu.uy |
Key Words |
Atypical diabetes; Clinical algorithm; Immunity molecular marker |
Core Tip |
There are evidences that exists a lot of patients who were diagnosed as type 2 diabetics but present difficult management, don’t have good responses to treatment and don’t achieve the metabolic goals. We include the study of human leukocyte antigen markers typically associated whit type 1 diabetes to characterize these patients. This paper provides information about the possibility of incorporate a standardized molecular diagnosis in the clinical practice to identify complex or atypical type 2 diabetic patient.
|
Publish Date |
2014-08-17 13:16 |
Citation |
Fernández M, Fabregat M, Javiel G, Mimbacas A. HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients. World J Diabetes 2014; 5(5): 711-716 |
URL |
http://www.wjgnet.com/1948-9358/full/v5/i5/711.htm |
DOI |
http://dx.doi.org/10.4239/wjd.v5.i5.711 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345